PF-5274857 free base · Synonyms: PF 5274857 · PF5274857
PF-5274857 is a potent, selective, orally active and brain-penetrant antagonist of Smo.
For research use only. Not for human or veterinary use.
PF-5274857 structure
CAS No.: 1373615-35-0
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 500 mg | USD 450.00 | BP-02143-500mg | In stock | Get quote |
| 1 g | USD 720.00 | BP-02143-1g | In stock | Get quote |
| 2 g | USD 1,120.00 | BP-02143-2g | In stock | Get quote |
| 3 g | USD 1,350.00 | BP-02143-3g | In stock | Get quote |
| 5 g | USD 2,800.00 | BP-02143-5g | In stock | Get quote |
Need another size or custom synthesis? Request a quote.
Description
PF-5274857 is a potent, selective, orally active and brain-penetrant antagonist of Smo, with an IC50 of 5.8 nM and Ki of 4.6 nM. PF-5274857 has potential for research of tumor types including brain tumors and brain metastasis driven by an activated Hh pathway .
Biological activity
In Vitro PF-5274857 completely inhibits Shh-induced Hh pathway activity with an IC50 of 2.7±1.4 nM measured by the transcriptional activity of Smo downstream gene Gli1 in MEF cells. PF-5274857 shows less than 20% inhibition against a broad panel of protein kinases at 1 μM. In Vivo PF-5274857 (1-30 mg/kg; p.o. once daily for 6 days) shows robust antitumor efficacy and correlation between PK and PD in medulloblastoma allograft mice models. PF-5274857 (10 mg/kg; i.h.) in the plasma is able to cross the blood-brain barrier in rats within 4 hours postdose. PF-5274857 (10-100 mg/kg; p.o. once daily for 4 days) is able to target Smo in the brain leading to the downregulation of Hh pathway activity in the brain tumor. PF-5274857 (30 mg/kg; p.o. once daily for 34 days) increases the survival rates of primary Ptch+/? p53?/? medulloblastoma mice. PF-5274857 (5-30 mg/kg; p.o.) exhibits the apparent volume of distribution of 5.6±0.5 L/kg and the half-life (T1/2) of 1.7±0.1 hours.
Identifiers
- SMILES
-
CC1=CN=C(C(C)=C1)C1=CC(=NC=C1Cl)N1CCN(CC1)C(=O)CCS(C)(=O)=O - InChIKey
-
BBVNTTZIOTWDSV-UHFFFAOYSA-N
Specifications
- MW (average)
- 436.9560
- Formula
- C20H25ClN4O3S
- CAS No.
- 1373615-35-0
- Physical state
- Solid
- Color
- Light yellow to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 3 years; 4℃ 2 years; In solvent -20℃ 1 year;
Solubility
Soluble in DMSO/H2O
Documents
References
Same research area
Search Cancer- BP-01858A Derazantinib hydrochloride salt · >98%
- BP-01861A Nirogacestat dihydrobromide salt · >98%
- BP-01900A IACS-010759 HCl salt · >98%
- BP-01923 Avapritinib free base · >98%
- BP-01924 BLU-554 free base · >99%
- BP-01925 ACY-1083 free base · >98%
- BP-01927 PHGDH-IN-5 free base · >98%
- BP-01928 Bortezomib free base · >99%